Business - Briefly   

GlaxoSmithKline to buyback shares

NEW DELHI, DEC. 10. The board of directors of GlaxoSmithKline Consumer Healthcare today approved the buyback of shares of Rs. 123 crores in a move to invest surplus funds to maximise shareholder value, representing 7.33 per cent of the company's share capital. The company will buy back shares at a price not to exceed Rs. 370 per equity share. — Our Special Correspondent

Printer friendly page  
Send this article to Friends by E-Mail

Business

News: Front Page | National | Tamil Nadu | Andhra Pradesh | Karnataka | Kerala | New Delhi | Other States | International | Opinion | Business | Sport | Miscellaneous | Engagements |
Advts: Classifieds | Employment | Obituary | Updates: Breaking News |

Stories in this Section

Inflation down, industrial growth up
Policies should focus on job generation, says Montek
LIC proposes two-part wage hike
Honda to synergise India, Thailand operations
Rupee crashes by 56 paise
Sensex drops 71 points
Greaves rolls out millionth engine
Tata Steel seeks IFC loan for NatSteel buy
Zylog to implement RTGS PayWare product
Chopra to head Corporation Bank
Schwing Stetter's expansion project
Don't say `data'; say `information'
TCS, Bharti, NTPC best employers - study
Anil Ambani, Kamath named ISB Icons
Bullion rates
Exchange rates
Bharat Forge buys German firm
GlaxoSmithKline to buyback shares
Upasana under SFL fold
Gateway Distriparks files draft prospectus
Avaya GlobalConnect's plans
New managing directors for LIC
New MD for Carlyle group
Rising raw material prices hit explosives units
Syndicate Bank Q2 business at Rs. 70,000 crores
Diamond for gold offer from Tanishq
Cosmic Air launches India operations
Gulf Oil lubricants division head
SriLankan Airlines wins three awards
Job fair at Kochi
Muthoot Fincorp to launch new scheme
Cash award for Kerala football team

Copyright © 2004, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu